Enanta Pharmaceuticals, Inc. (NASDAQ:ENTA) Shares Sold by UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC
UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC lessened its position in Enanta Pharmaceuticals, Inc. (NASDAQ:ENTA – Free Report) by 6.4% during the fourth quarter, Holdings Channel reports. The fund owned 159,729 shares of the biotechnology company’s stock after selling 10,886 shares during the quarter. UBS AM a distinct business unit […]
